It has been posted here many times, this is a long term investment,the exception being a buyout, which I still believe will happen in the future. Certainly nobody who posts here, no matter what your position, believes that 7 employees are going to take a product national. Not going to happen. You just don't call Walgreens, CVS, etc on the phone and say we have a great product and we want to sell it in your stores. It's not that easy, or that inexpensive. It takes a lot of time, effort and money to make that happen. Product presentations, demonstrations, test markets, major retailers don't make authorization decisions at the end of a one hour meeting. This whole process takes time, and more than 7 employees. Travel expenses, fuel expenses, etc..Given the maximum productivity that 7 people can produce, ATTD's 7 have far exceeded any type of expectations at this point with the position they have already developed in the marketplace. Because that's what this is all about, this is where the money is coming from. It's all about Phase III. Talk about chills, reverse splits,increase in the authorized, etc etc etc...what it comes down to is the product, and the revenue potential it has longterm. The share price longterm will reflect the market success or failure of Phase III. I would be curious to hear about anyone who has Phase III in their area have seen any 2/$5 sales. With the Consumer Reports article on MusMilk, this beverage segment is screaming for quality, and at the same or better price point. Phase III has both. A major chain will not be carrying some Ensure 6 pack items in the Diet/Nutriiton section anymore. Retailers will not keep products on the shelf that are not turning. They will replace them with something they believe will turn. Why didn't the consumer buy these products, because the taste is horrible. Phase III taste is second to none in this market segment right now. What does that equate to in terms of annual revenue? Take Muscle Milks annual sales estimate at 300M, currently Pepsi is selling MusMilk to retailers at a cost of a little over $27 a case. Do the math, 300M divided by $27...that is well in excess of 10 million cases a year, more like 12M, they are selling right now, and Phase III is a superior product in every way possible. With the cross marketing potential here, that Roy has talked about, Phase III could easily sell 15-20M cases probably more a year at it's fullest potential. If the numbers are there for Walgreens, they would give serious consideration to permanent placement in the diet/nutrition section for Phase III, and would be handled as a warehouse delivery direct to the regional DC's, rather than DSD. Do not underestimate the market share/revenue dollars available in that segment. We lack money and people right now. Start ups, especially in the beverage industry, require more capital than most can imagine, doing business in the beverage industry doesn't come cheap..That's why the market share is so essential, that's the payback..Sirius XM Radio had annual revenue last year of 3M, with an outstanding share total of 3.8B...stock closed yesterday at $2.26 a share..SIRI is living proof that a stock like ATTD can win in this market. Of course, these are all my opinions..GLTA ATTD
AI
